Market Newsdesk

ValueH’s ACO network will build the foundation of Clover’s provider growth in the state

Partnership will bring providers onto the Clover Assistant Platform to increase value to fee-for-service Medicare Beneficiaries

NASHVILLE, Tenn., Aug. 03, 2021 (GLOBE NEWSWIRE) — Today, Clover Health (Nasdaq: CLOV) (“Clover”), an innovative technology company committed to improving health equity for America’s underserved seniors, announced a strategic partnership with ValueH, a leading member organization focused on Value-Based Care. Through the arrangement, ValueH will support Accountable Care Organizations (ACOs) and Management Services Organizations (MSOs) participating in Clover’s Direct Contracting Entity beginning in 2022.

Clover’s DCE will enable providers to manage the care of their Original Medicare patients with the Clover Assistant. The Clover Assistant is a clinical software tool used by doctors at the point of care to provide them with data-driven, personalized recommendations to improve how they care for their patients. Participating providers can benefit from:

• Unified, Actionable Data: access lab results, prescription lists, and previous diagnoses, including those from other clinicians
• Personalized Care Plans: receive and share new information at each patient visit and have access to clinical decision support
• Simple, Fast Reimbursement: receive the Clover Assistant reimbursement within seven days for each patient seen with the Clover Assistant

“We are excited to partner with ValueH to help support our efforts to increase the quality of care delivered to patients while simultaneously lowering medical costs,” said Kevin Murphy, Executive Director of Clover Health Partners. “We believe Direct Contracting has the potential to increase the growth of value-based models, specifically for the Medicare population.”

“The team at ValueH has deep experience with value-based care, best practices, and enablement services that they share with Florida accountable care organizations and managed care organization leaders,” said Kelly Conroy, Chief Executive Officer of ValueH. “Our partnership with Clover allows us to continue to champion independent practices while enhancing each entity’s ability to make measurable improvements in care.”

Clover Health Partners has seen significant traction as a Direct Contracting Entity since it began participating in the Centers for Medicare & Medicaid Services’ Global and Professional Direct Contracting Model. As of April 1, 2021, it had contracted with approximately 1,800 individual providers across eight states and had over 65,000 claims aligned beneficiaries.

About Clover Health

Clover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans. While our mission is to improve every life, we particularly focus on seniors who have historically lacked access to affordable high quality healthcare.

We aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. We do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. This strategy is underpinned by the company’s proprietary software platform, the Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by providing physicians with real-time, personalized recommendations at the point of care.

Making care more accessible is at the heart of our business, and we believe patients should have the freedom to choose their doctors. We offer two models of care: affordable Medicare Advantage plans with extensive benefits; and care coordination for Original Medicare beneficiaries through Direct Contracting. For both programs, we provide primary care physicians with the Clover Assistant and also make comprehensive home-based care available via the Clover Home Care program.

With its corporate headquarters in Nashville, Clover’s workforce is distributed around the U.S. and also includes a team of world-class technologists based in Hong Kong. The company manages care for Medicare beneficiaries in eleven states, including Arizona, Georgia, Kansas, Mississippi, New Jersey, New York, Pennsylvania, South Carolina, Tennessee, Texas and Vermont.

About ValueH

The ValueH Network is an ecosystem of the best providers in the State of Florida. It is made up of Accountable Care Organization Providers and Clinically Integrated Network Providers that rank at the top in their Quality and Cost metrics. VALUEH aggregates the best and uses that to negotiate contracts that result in maximum income while managing risk on its partners’ behalf. Visit www.ValueH.com to learn more.

Press Contact: 

Andrew Still-Baxter
[email protected]

LEAWOOD, Kan., Aug. 03, 2021 (GLOBE NEWSWIRE) — Euronet Worldwide, Inc. (NASDAQ: EEFT), a leading global financial technology solutions and payments provider, announced today the details for its North America 2021 ENGAGE Payments Solutions and Innovations Conference, an event for technology and business leaders who are driving modernization and digital transformation strategies at fintechs, retailers and financial institutions.

The two-day ENGAGE conference will be held in New York City at the Marriott Marquis on Oct. 4-5, 2021.

Conference speakers include Tim Winston, Senior Assurance Consultant, Amazon Web Services, who will address the security and industry compliance standards required when utilizing cloud services to improve agility and global reach. Additionally, Aser Blanco, Head of Americas, Google Cloud Financial Services, will address best practices for leveraging the cloud for financial services.

Other noted speakers and highlights include:

• Greg Orme, programme director at the London Business School and globally acclaimed speaker and author, will present on how to redefine leadership skills to succeed in an increasingly fast-paced world. “This is a ‘must attend’ conference whether you’re a fintech or large bank because the way payments are being switched and processed around the world is changing at an accelerating pace,” Orme said. “To stay ahead of the disruption, you need to know about the most innovative technology available. Come and see what’s happening at the cutting edge – you’ll be glad you did.”
• Dr. Martin Brückner, Euronet Senior Vice President and Chief Technology Officer, will present on the implementation of seamless connections to real time payments networks and other innovations provided by Euronet’s REN payments technology.
• Forrester Research will provide insight into how evolving consumer expectations are driving the need for real time payments globally and explain the challenges financial institutions must overcome to become an efficient participant in real time payments networks.
• Expert discussion panels with leaders from the financial and payments industries will cover innovation journeys in their organizations, the power of data to engage customers and build loyalty and other critical issues facing businesses today.

There is no registration fee to attend the conference. However, space is limited and must be reserved. Prospective attendees can visit the Euronet Software Solutions website at https://www.euronetsoftware.com/engage-nyc-2021/ to register, read the full conference agenda and book accommodations under the hotel’s conference group rates.

About Euronet Worldwide, Inc.

Euronet Worldwide is an industry leader in processing secure electronic financial transactions. The Company offers payment and transaction processing solutions to financial institutions, retailers, service providers and individual consumers. These services include comprehensive ATM, POS and card outsourcing services, card issuing and merchant acquiring services, software solutions, cash-based and online-initiated consumer-to-consumer and business-to-business money transfer services, and electronic distribution of digital media and prepaid mobile phone time.

Euronet’s global payment network is extensive – including 46,246 owned and operated ATMs, approximately 375,000 EFT POS terminals and a growing portfolio of outsourced debit and credit card services which are under management in 61 countries; card software solutions; a prepaid processing network of approximately 748,000 POS terminals at approximately 333,000 retailer locations in 60 countries; and a global money transfer network of approximately 490,000 locations serving 160 countries. With corporate headquarters in Leawood, Kansas, USA, and 66 worldwide offices, Euronet serves clients in approximately 175 countries. For more information, please visit the Company’s website at www.euronetworldwide.com.

Contact
Stephanie Taylor
Director of Financial Planning and Investor Relations
Euronet Worldwide, Inc.
+1-913-327-4200
[email protected]

SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) today announced that Corey Staten has joined the firm as executive vice president, Service, effective today. In this role, Staten leads the Service organization, including the Service Center, Specialized Service Teams, Technical Support Help Desk, and New Advisor Care Team. He is also responsible for leading the Care Transformation for Service, working in partnership with stakeholders across the firm to deliver a next-generation, industry-leading service experience to LPL advisors, RIAs and institutions. He reports to LPL Chief Customer Care Officer and Managing Director Dayton Semerjian and is based in LPL’s San Diego office.

“Corey is a passionate and strategic leader with a depth of experience designing and delivering client-centric service experiences for a large client base. Importantly, he appreciates the balance between human and digital engagement to do more than just deliver, but delight, clients, and the continuous improvement that requires,” said Semerjian. “As a leader, he has steered diversity recruitment strategies and initiatives on career pathing, incentives and talent management, understanding that great employees power a great advisor experience. Corey will be a tremendous asset to our team and our clients to support our mission and be the industry leader in client care.”

Staten joins LPL from JPMorgan Chase & Co., where he served as managing director, Merchant Services Operations, servicing small business customers. In that role, he helped drive the organization’s digital transformation strategy, making it easier for clients to do business via web and mobile capabilities. Prior to JPMorgan, he held leadership roles at Charles Schwab, including senior vice president, Client Service & Support, and American Express, where he oversaw operational risk and customer care support teams and directed continuous improvement initiatives at scale. Staten earned a bachelor of science in industrial engineering from North Carolina A&T State University.

“I am honored to join the LPL family and work closely with the talented Care organization employees, all of whom support the quality advisors, RIAs and institutional programs who call LPL home,” said Staten. “LPL has a distinguished history of taking care of its advisors, and I look forward to accelerating our service strategy to make it easier for them to take care of their clients.”

Staten succeeds Tim Hodge, who joined LPL in 2015. Semerjian said, “Tim has played a key role in evolving the LPL service experience over the past six years and helped lay the groundwork for LPL’s service transformation journey. We wish him all the best.”

About LPL Financial


LPL Financial (Nasdaq: LPLA) was founded on the principle that the firm should work for the advisor, and not the other way around. Today, LPL is a leader* in the markets we serve, supporting more than 19,000 financial advisors, 800 institution-based investment programs and 450 independent RIA firms nationwide. We are steadfast in our commitment to the advisor-centered model and the belief that Americans deserve access to objective guidance from a financial advisor. At LPL, independence means that advisors have the freedom they deserve to choose the business model, services, and technology resources that allow them to run their perfect practice. And they have the freedom to manage their client relationships, because they know their clients best. Simply put, we take care of our advisors, so they can take care of their clients.

* Top RIA custodian (Cerulli Associates, 2019 U.S. RIA Marketplace Report)
No. 1 Independent Broker-Dealer in the U.S. (Based on total revenues, Financial Planning magazine June 1996-2020)
No. 1 provider of third-party brokerage services to banks and credit unions (2019-2021 Kehrer Bielan Research & Consulting Annual TPM Report); Fortune 500 company as of June 2021

Securities and Advisory services offered through LPL Financial LLC, a registered investment advisor. Member FINRA/SIPC.

Throughout this communication, the terms “financial advisors” and “advisors” are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial LLC. We routinely disclose information that may be important to shareholders in the “Investor Relations” or “Press Releases” section of our website.

Connect with Us!

https://twitter.com/lpl

https://www.linkedin.com/company/lpl-financial

https://www.facebook.com/LPLFinancialLLC

https://www.youtube.com/user/lplfinancialllc

Media Contact:

Lauren Hoyt-Williams
(813) 351-9203
[email protected]

TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) — ISA Cybersecurity today announced that it is now delivering Proofpoint’s industry-leading secure email solutions as a managed service offering. A first in the Canadian marketplace, this partnership will bring affordable, best-in-class email security solutions to companies of all sizes, right across the country.

ISA Cybersecurity’s enterprise-grade and field-proven cloud security services and Proofpoint’s best-in-class email security and protection solutions address the growing dangers of email-based cyber threats: Proofpoint’s 2021 State of the Phish report reveals that 57% of respondents said their organization dealt with a successful phishing attack in 2020, and more than 75% of organizations said they faced broad-based phishing attacks.

The partnership will help protect people on every channel, including email, web, cloud, social media and mobile messaging. The managed services platform will provide the ability to control, secure and monitor inbound and outbound messages, and will deliver extended threat prevention capabilities – in real time – giving customers increased visibility and comprehensive protection against today’s advanced threats.

The announcement is an extension of an already strong relationship. ISA Cybersecurity was named Proofpoint’s Fastest-growing Canadian Regional Partner of 2020 earlier this year, and is recognized as a Proofpoint “Trusted Partner”, confirming ISA Cybersecurity’s reputation of success in working with customers on their Proofpoint implementations.

“Proofpoint is a perfect fit for us. We have years of experience working together to deliver Proofpoint’s cloud-based DLP and email protection solutions for our customers. This new managed services partnership will put advanced email security within the reach of even more Canadian public and private sector organizations,” said Kevin Dawson, President and CEO, ISA Cybersecurity.

“We are excited to join ISA Cybersecurity’s impressive roster of managed service offerings. ISA Cybersecurity has shown strong commitment and expertise with Proofpoint products, and is the first Proofpoint partner in Canada to offer this type of service. This partnership will make it even faster and easier for companies to protect themselves against the scourge of phishing and other email-based threats,” said Joe Sykora, Senior Vice President of Worldwide Channel and Partners, Proofpoint.

To learn more about the new service offering, contact ISA Cybersecurity today. To learn more about our partnership, visit our partner page https://www.isacybersecurity.com/proofpoint.

About ISA Cybersecurity

ISA Cybersecurity is Canada’s leading cybersecurity-focused company, with nearly three decades of experience providing customers with advisory and technical services on complex and evolving issues related to cybersecurity. Their vision is to help create a world in which everyone is safe from cyber threats. They are recognized by IDC MarketScape as a Major Player in Canadian Security Services, with offices in Toronto, Ottawa, and Calgary, and operating multiple 24/7/365, SOC 2 Type 2 security operations centres. ISA Cybersecurity delivers cybersecurity services and people you can trust. Learn more at www.isacybersecurity.com.

About Proofpoint

Proofpoint, Inc. (NASDAQ: PFPT) is a leading cybersecurity and compliance company that protects organizations’ greatest assets and biggest risks: their people. With an integrated suite of cloudbased solutions, Proofpoint helps companies around the world stop targeted threats, safeguard their data, and make their users more resilient against cyber attacks. Leading organizations of all sizes, including more than half of the Fortune 1000, rely on Proofpoint for people-centric security and compliance solutions that mitigate their most critical risks across email, the cloud, social media, and the web. More information is available at www.proofpoint.com.

Media Contact:
Lindsay Ringuette
Director, Marketing
[email protected]
(647) 571-9026

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b122edfb-3982-4255-92ec-76f69f96c3e9.

30+ Year Industry Veteran to Steer Company’s IT Vision, including Security Best Practices and M&A Integration

BEDFORD, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact business applications, today announced the appointment of Ian Pitt as its new Chief Information Officer (CIO). With more than 30 years of information technology leadership experience, Mr. Pitt will be responsible for driving the vision, strategy and operations of Progress’ global IT organization. He will also lead Progress’ ongoing efforts to safeguard its networks, infrastructure, business applications and products with best-in-class internal and customer-facing security practices. As CIO, Mr. Pitt will report to CEO Yogesh Gupta.

“IT is critical to the success of our total growth strategy. Ian’s proven experience will ensure our IT function will drive innovation and efficiency that will help propel Progress forward,” said Yogesh Gupta, CEO, Progress. “At the same time, Ian’s experience successfully advancing and evangelizing security best practices is an important benefit to our business. This is especially true in today’s environment where the level of sophistication, volume and speed of new threats is growing at an alarming rate. In Ian, we are fortunate to work with an industry veteran who has experience in leveraging technology and talent to achieve business results.”

In addition to his core areas of focus, Mr. Pitt will partner with company leaders to support Progress’ M&A growth strategy by seamlessly integrating newly acquired companies and technology and will ensure that Progress® systems deliver world-class experiences to employees and customers. This includes leading the assessment and application of existing and new technologies to securely improve operational efficiency.

“It is a privilege to join a company like Progress that has a true vision and commitment to driving innovation and digital transformation for organizations, on a global scale,” said Mr. Pitt. “I look forward to leading operational efforts and strategies that align with that vision, supporting Progress’ customers and employees as we continue to grow.”

Mr. Pitt has deep technology strategy and execution experience, most recently serving as Senior Vice President and CIO at LogMeIn. At LogMeIn, he was responsible for corporate IT, including acquisition integration, cybersecurity, governance, business applications and product operations. Prior to LogMeIn, he served as CIO of Thunderhead and CTO of Chordiant Software (acquired by Pega) and also headed research and technology at TCS.

He attended Lancaster University in the UK, graduating with a BSc in Engineering and Physics, and currently sits on the advisory board of BostonCIO, the preeminent peer leadership network for New England’s leading chief information officers.

Additional Resources

• Follow Progress on Twitter, Facebook and LinkedIn
• Read the Progress blog

About Progress

Progress (NASDAQ: PRGS) provides the best products to develop, deploy and manage high-impact business applications. Our comprehensive product stack is designed to make technology teams more productive, and we have a deep commitment to the developer community, both open source and commercial alike. With Progress, organizations can accelerate the creation and delivery of strategic business applications, automate the process by which apps are configured, deployed and scaled, and make critical data and content more accessible and secure – leading to competitive differentiation and business success. Over 1,700 independent software vendors, 100,000+ enterprise customers and a three-million-strong developer community rely on Progress to power their applications. Learn about Progress at www.progress.com or +1-800-477-6473.

Progress is a trademark or registered trademark of Progress Software Corporation and/or one of its subsidiaries or affiliates in the US and other countries. Any other trademarks contained herein are the property of their respective owners.

Press Contacts:           
Kim Baker           
Progress        
+1 781-280-4000          
[email protected]

A Media Snippet accompanying this announcement is available by clicking on the image or link below: 

Ian Pitt: Ian Pitt, Chief Information Officer, Progress Software

 

SANTA MONICA, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — GoodRx, Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, today shared the results of a recent consumer survey showing the company’s impact on pharmacy retailers. Findings indicate that GoodRx helps pharmacies boost sales by driving in-store foot traffic, improving customer loyalty, and increasing medication affordability and access for their customers.

GoodRx offers discounts at pharmacies across the country, including major chains like Albertsons, CVS, Costco, Kroger, Rite Aid, Walmart and Walgreens, to help consumers save money on the prescriptions they need. For those looking for even greater discounts, GoodRx offers a subscription savings program, GoodRx Gold, which provides savings of up to 90% off the pharmacy retail (or usual and customary) price on prescription drugs at participating pharmacies nationwide.

GoodRx recently surveyed over 4,000 users of GoodRx coupons and GoodRx Gold and found that these users reported the following, which could benefit pharmacy retailers:

• Increase medication affordability and adherence for customers: Prior to using GoodRx, only 23% of consumers surveyed could afford all of their prescriptions, while after using GoodRx, that number skyrocketed to 81% of consumers surveyed being able to afford all of their medication. Medication affordability can help pharmacies reduce “walk away” patients and prescriptions abandoned at the counter due to high cost, and increase medication adherence for their customers.
• Sales through additional foot traffic: Almost 80% of consumers surveyed said they purchased other items such as general merchandise or groceries when picking up a prescription, spending an additional $40 or more on average at the pharmacy counter.
• Encourage pharmacy loyalty among customers: 85% of consumers surveyed agree that their positive experience with GoodRx makes them want to return to their pharmacy. 65% of consumers who use GoodRx reported visiting their pharmacy at least once a month, with 26% making additional trips because of GoodRx.
• Lead to high consumer satisfaction: 95% of consumers surveyed had a good or excellent experience using GoodRx.

“Our mission has always been to provide Americans with access to affordable healthcare and we continue to work with partners across the healthcare ecosystem to drive down medication costs,” said Bansi Nagji, President of Healthcare at GoodRx. “By offering discounts at nearly every major retail pharmacy in the U.S., we ensure their customers can afford their prescriptions and, in turn, help the retailers improve customer loyalty, increase foot traffic and ensure a positive experience at the pharmacy counter.”

To learn more about GoodRx, visit: goodrx.com.

About GoodRx

GoodRx helps Americans get the healthcare they need at a price they can afford. As America’s leading resource for healthcare savings, GoodRx connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail order prescriptions, doctor visits, and lab tests. We have helped Americans save over $30 billion since 2011 and are one of the most downloaded medical apps over the past decade.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the benefits of GoodRx’s offerings for pharmacy retailers and GoodRx’s impact on the healthcare ecosystem. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to risks related to our limited operating history and early stage of growth; our ability to achieve broad market education and change consumer purchasing habits; our ability to continue to attract, acquire and retain consumers in a cost-effective manner; our reliance on our prescription offering and ability to expand our offerings; changes in medication pricing and pricing structures; and the important factors discussed under the caption “Risk Factors” in GoodRx’s Annual Report on Form 10-K for the year ended December 31, 2020, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Contact

GoodRx
Lauren Casparis
[email protected]

GLENDALE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — LegalZoom.com, Inc. (NASDAQ: LZ), the leading online platform for legal and compliance services, has appointed Elizabeth (Liz) Hamren, corporate vice president for gaming experiences and platforms at Microsoft, to its board of directors.

LegalZoom, which completed its initial public offering in June 2021, has added independent members to its board of directors in recent months. Hamren brings to the board an extensive background in engineering, product management, marketing and operations for subscription-based technology products. For the past three years, she has led product and engineering for Xbox consumer products and services, including the flagship Xbox Game Pass subscription service, Xbox hardware and platform software, and PC experiences. Before Gaming, she led marketing and business for Microsoft devices.

Prior to her role at Microsoft, Hamren led global marketing and sales for Oculus at Facebook and launched the industry-defining Oculus Rift virtual reality headset. She also ran marketing, subscriptions, and direct sales for Dropcam, growing its user base by 10x before the company was sold to Google/Nest. Earlier in her career, Hamren held product and marketing leadership positions at public and private companies including Plantronics, Jawbone and OQO.

“Liz brings a wealth of relevant experience to our board and will be a tremendous resource as we continue to grow our customer base and expand our products and services for small business owners and aspiring entrepreneurs,” said LegalZoom CEO Dan Wernikoff. “She has first-hand experience launching and scaling some of the most popular consumer technology and subscription-based services in the world. I’m excited to work with her as we continue our growth and fulfill our mission to democratize law.”

“I’m inspired by LegalZoom’s mission to make legal services more affordable and accessible to entrepreneurs and individuals who want legal protections for themselves and their families,” Hamren said. “I am eager to work alongside Dan and the other directors to guide the company’s continued success and bring my experience and perspective to further the LegalZoom mission.”

In addition to her executive leadership roles, Hamren has served on the boards of Owl Cameras, Plume Design, SNUPI Technologies and Cozi. She has a BSE in Civil Engineering and Operations Research from Princeton University and an MBA from Harvard Business School.

About LegalZoom


LegalZoom is a leading online platform for legal and compliance solutions in the United States that is on a mission to democratize law. LegalZoom operates across all 50 states and over 3,000 counties in the United States and has more than 20 years of experience navigating complex regulations and simplifying the legal and compliance process for its customers. Driven by its core value that every business deserves the full protection of the legal system and a simple way to stay compliant with it, LegalZoom helps its customers form and protect their businesses, their ideas and families. In 2020, 10% of all new LLCs and 5% of all new corporations in the United States were formed through LegalZoom, enabling small business owners to apply their energy and passion to their businesses instead of the legal and regulatory complexity required to operate them. In addition to business formations, LegalZoom offers ongoing compliance and tax advice, trademark and copyright filings and estate planning documents to protect small businesses and the families that create them.

Contact


Allison+Partners
Alexandra Gardell Kreuter
[email protected]

 

• After COVI-STIX™ (COVID-19 VIRUS RAPID ANTIGEN DETECTION TEST) obtained Emergency Use Authorization (EUA) approval from the Mexican Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), Sorrento and Mexican INMEGEN (“Instituto Nacional de Medicina Genomica”) have held meetings to explore collaboration.
• Sorrento Therapeutics Mexico (“Sorrento Mexico”) and INMEGEN have executed an MOU to further collaborate on clinical development of a broad pipeline of COVID products, including diagnostics, multivalent mRNA-based vaccines and therapeutics. Sorrento provides its most comprehensive portfolios and a “one-stop-shop” of potential solutions for governments interested in a multi-modal “detect and treat” approach to the COVID-19 pandemic.
• Sorrento Mexico plans to install local clinical research and development capabilities within the INMEGEN facilities and personnel in Mexico City and will work closely with Mexican hospitals and clinical institutions on clinical protocols, regulatory registration and approval requirements for the COVID-19 product development.

SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that its subsidiary company, Sorrento Therapeutics Mexico (“Sorrento Mexico”), has entered into an MOU agreement with the National Institute of Genomic Medicine INMEGEN (“Instituto National de Medicine Genomica”) to cooperate in the development, testing and support of multiple COVID-19 related products Sorrento plans to commercialize in Mexico.

Sorrento Mexico and INMEGEN will expand its collaboration to include additional Sorrento COVID pipeline products spanning diagnostics, therapeutics and multivalent vaccines, including the following product candidates:

• COVITRACK™: COVID-19 antibody detection diagnostic test for vaccinated people;
• STI-2020 (COVI-AMG™): Affinity matured neutralizing antibody against SARS-CoV-2 for outpatient COVID patients;
• STI-2099 (COVIDROPS™): Intranasal neutralizing antibody version of COVI-AMG for newly diagnosed COVID patients;
• COVISHIELD™: Cocktail of neutralizing antibodies against variants of concern of SARS-CoV-2;
• STI-5656 (Abivertinib): BTK inhibitor for the treatment of acute respiratory distress syndrome (ARDS) in hospitalized COVID patients;
• STI-8282 (COVI-MSC™): Allogeneic mesenchymal stem cells for the treatment of COVID-associated ARDS in severe COVID patients; and
• Multivalent mRNA Vaccines: mRNA-based multivariant vaccines protecting against SARS-CoV-2 virus, Alpha, Beta, Delta and Gamma variants of concern.

Sorrento Mexico plans to establish a local research laboratory within INMEGEN’s facilities to ensure close collaboration between the INMEGEN and Sorrento teams for testing, clinical trials and development of COVID related products.

“We are excited about our close collaboration with INMEGEN and intend to have Sorrento Mexico as a gateway to all Latin American countries for our innovative COVID diagnostic, vaccine and therapeutic product candidates,” said Henry Ji, Ph.D., Chairman and CEO of Sorrento Therapeutics.

About Sorrento Therapeutics, Inc.

Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers and COVID-19. Sorrento’s multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies (“G-MAB™ library”), clinical stage immuno-cellular therapies (“CAR-T”, “DAR-T™”), antibody-drug conjugates (“ADCs”), and clinical stage oncolytic virus (“Seprehvir™”). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including COVIGUARD™, COVI-AMG™, COVISHIELD™, Gene-MAb™, COVI-MSC™ and COVIDROPS™; and diagnostic test solutions, including COVITRACK™, COVI-STIX™ and COVITRACE™.

Sorrento’s commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a first-in-class (TRPV1 agonist) non-opioid pain management small molecule, resiniferatoxin (“RTX”), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido^® (lidocaine topical system) 1.8% for the treatment of post-herpetic neuralgia. RTX has completed a Phase IB trial for intractable pain associated with cancer and a Phase 1B trial in osteoarthritis patients. SEMDEXA is in a pivotal Phase 3 trial for the treatment of lumbosacral radicular pain, or sciatica. ZTlido^® was approved by the FDA on February 28, 2018.

For more information visit www.sorrentotherapeutics.com.

Forward-Looking Statements

This press release and any statements made for and during any presentation or meeting contain forward-looking statements related to Sorrento Therapeutics, Inc., under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995 and subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements regarding Sorrento’s expectations regarding the collaboration between INMEGEN and Sorrento to conduct clinical development activities for Sorrento’s COVID-19 related diagnostics, therapeutics and vaccine product candidates in Mexico, including testing, clinical trials and product development; the installation of clinical research and development capabilities within INMEGEN; the plan to work with Mexican hospitals and clinical institutions on clinical and regulatory activities; and Sorrento’s potential position in the diagnostics, therapeutics and vaccine industries. Risks and uncertainties that could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements, include, but are not limited to: risks related to Sorrento’s and its subsidiaries’, affiliates’ and partners’ technologies and prospects and collaborations with partners, including, but not limited to risks related to seeking regulatory approval for Sorrento’s COVID-19 products in Mexico and Latin America; clinical development risks, including risks in the progress, timing, cost, and results of clinical trials and product development programs; risk of difficulties or delays in obtaining regulatory approvals; risks that clinical study results may not meet any or all endpoints of a clinical study and that any data generated from such studies may not support a regulatory submission or approval; risks that prior test, study and trial results may not be replicated in future studies and trials; risks of manufacturing and supplying drug product; risks related to leveraging the expertise of its employees, subsidiaries, affiliates and partners to assist Sorrento in the execution of its therapeutic antibody product candidate strategies; risks related to the global impact of COVID-19; and other risks that are described in Sorrento’s most recent periodic reports filed with the Securities and Exchange Commission, including Sorrento’s Annual Report on Form 10-K for the year ended December 31, 2020, and subsequent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission, including the risk factors set forth in those filings. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release and we undertake no obligation to update any forward-looking statement in this press release except as required by law.

Media and Investor Relations Contact


Alexis Nahama, DVM (SVP Corporate Development)
Email: [email protected]

Sorrento^® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.

G-MAB™, DAR-T™, SOFUSA™, COVIGUARD™, COVI-AMG™, COVISHIELD™, Gene-MAb™, COVIDROPS™, COVI-MSC™, COVITRACK™, COVITRACE™ and COVI-STIX™ are trademarks of Sorrento Therapeutics, Inc.

SEMDEXA™ is a trademark of Semnur Pharmaceuticals, Inc.

ZTlido^® is a registered trademark owned by Scilex Pharmaceuticals Inc.

All other trademarks are the property of their respective owners.

©2021 Sorrento Therapeutics, Inc. All Rights Reserved.

 

CHARLOTTE, N.C., Aug. 03, 2021 (GLOBE NEWSWIRE) — SPX Corporation (“SPX”) (NYSE: SPXC) today announced that it has completed the acquisition of Enterprise Control Systems Ltd (“ECS”). Headquartered near Northampton, UK, ECS is a leader in the design and manufacture of highly-engineered tactical datalinks and radio frequency (RF) countermeasures, including counter-drone and counter-IED RF jammers.

ECS’s results will be reported as part of SPX’s Communications Technology (“CommTech”) platform within its Detection & Measurement segment. SPX anticipates updating 2021 guidance to reflect ECS when reporting Q2 2021 results on August 5^th, and currently anticipates that, in the near-term, ECS will contribute annualized revenue of approximately $14 million. ECS is expected to be accretive to Detection & Measurement segment margin once fully integrated.

“We are excited to welcome ECS to the SPX team,” said Gene Lowe, President and CEO of SPX. “As our first acquisition in our CommTech platform, ECS expands and strengthens SPX’s position in COMINT by adding highly complementary, world-class products and technology. We see significant opportunities to grow our presence in COMINT, and complementary technologies and solutions worldwide. We view ECS’s expertise in encrypted data link systems and RF countermeasures as a perfect fit with the high-value RF monitoring, detect and locate technologies and products of our TCI business.”

Colin Bullock, founder of ECS, commented, “We are very pleased to be part of SPX, as it creates numerous opportunities for employees and customers to continue our growth journey. Combining ECS’s expertise in RF countermeasures and encrypted data links systems with SPX’s strengths in RF detection and location systems, as well as its global infrastructure and resources, is a great opportunity to further advance product development and extend the reach of our combined, high-value solutions to a broader customer base.”

About SPX Corporation:  SPX Corporation is a supplier of highly engineered products and technologies, holding leadership positions in the HVAC and detection and measurement markets. Based in Charlotte, North Carolina, SPX Corporation had more than 4,500 employees in 15 countries. SPX Corporation is listed on the New York Stock Exchange under the ticker symbol “SPXC.” For more information, please visit www.spx.com.

About Enterprise Control Systems Ltd:  Enterprise Control Systems Ltd is a leading designer and manufacturer of highly-engineered communications intelligence systems, including RF inhibitors (RF Jammers) and encrypted data links. Headquartered near Northampton, UK, ECS was founded in 1988, and has grown steadily in size over the past 30 years. For more information, please visit www.enterprisecontrol.co.uk.

Forward-looking Statements. Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. In addition to our updated 2021 financial guidance, the words “believe,” “expect,” “anticipate,” “project” and similar expressions identify our other forward-looking statements. Please read these forward-looking statements in conjunction with our documents filed with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and quarterly report on Form 10-Q. These filings identify important risk factors and other uncertainties that could cause actual results to differ from those contained in the forward-looking statements, including the following: the impact of the COVID-19 pandemic and governmental and other actions taken in response; the uncertainty of claims resolution with respect to the large power projects in South Africa, as well as claims with respect to asbestos, environmental and other contingent liabilities; cyclical changes and specific industry events in our markets; changes in anticipated capital investment and maintenance expenditures by customers; availability, limitations or cost increases of raw materials and/or commodities that cannot be recovered in product pricing; the impact of competition on profit margins and our ability to maintain or increase market share; inadequate performance by third-party suppliers and subcontractors for outsourced products, components and services; cyber-security risks; risks with respect to the protection of intellectual property, including with respect to our digitalization initiatives; the impact of overruns, inflation and the incurrence of delays with respect to long-term fixed-price contracts; defects or errors in current or planned products; domestic economic, political, legal, accounting and business developments adversely affecting our business, including regulatory changes; changes in worldwide economic conditions; uncertainties with respect to our ability to identify acceptable acquisition targets; uncertainties surrounding timing and successful completion of any announced acquisition or disposition transactions (including the disposition of SPX Transformer Solutions, Inc.), including uncertainties with respect to obtaining (and the timing of) necessary regulatory approvals; uncertainties with respect to integrating acquisitions and achieving cost savings or other benefits from acquisitions; the impact of retained liabilities of disposed businesses; potential labor disputes; and extreme weather conditions and natural and other disasters.

Actual results may differ materially from these statements. Although SPX believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct.

Statements in this press release speak only as of the date of this press release, and SPX disclaims any responsibility to update or revise such statements except as may be required by law.

Investor and Media Contacts:

Paul Clegg, Vice President, Investor Relations and Communications
Phone: 980-474-3806
E-mail: [email protected] 

Nick Illuminati, Manager, Investor Relations
Phone: 980-474-3806
E-mail: [email protected] 

Source: SPX Corporation 

Key Benefits:

• PCIe^® 4.0 NVMe™ technology with up to 6600MB/s sequential reads¹
• Engineered for gamers, professionals, and creatives requiring high-performance storage products
• Incorporates Micron^® advanced 176L TLC 3D NAND and innovative controller technology
• Rated at MTTF greater than 2 million hours for extended longevity and reliability²

BOISE, Idaho, Aug. 03, 2021 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today announced the immediate availability of Crucial P5 Plus PCIe SSDs as an expansion of its award-winning NVMe solid-state drive (SSD) portfolio to offer high-performance internal Gen4 storage options to consumers. By leveraging Micron’s first-to-market volume shipments of 176-layer NAND, Crucial P5 Plus SSDs enable lower power, higher speed, and denser storage solutions. Additionally, Micron’s advanced 176L 3D TLC NAND and innovative controller technology, yields up to 66% faster sequential write speeds and nearly double the sequential reads of prior generation Crucial SSDs³.

“With data intensive workloads on the rise, consumers increasingly demand high-performance storage solutions for their needs including engineering applications, video editing, content creation and gaming,” said Teresa Kelley, vice president and general manager of Micron’s Consumer Products Group. “By using our powerful, industry-leading 176-layer 3D NAND, coupled with the latest high-bandwidth storage interface, the P5 Plus Gen4 SSD makes lightning-fast computing storage accessible for a broad spectrum of consumers in the market.”

With read speeds up to 6600MB/s, Crucial P5 Plus SSDs also enable up to 67% faster random read and 40% faster random write performance over prior Crucial Gen3 SSDs⁴. Ideal for a new PCIe Gen4 PC build or a PCIe Gen3 system upgrade, the P5 Plus is compatible with both and has been tested on Intel and AMD platforms including the latest 11th Generation Intel^® Core^™ processors and AMD Ryzen 3000 PCIe 4.0 motherboards. Likewise, these new Crucial PCIe Gen4 SSDs are backward compatible for most Gen3 PC systems that support M.2 form factors⁵.

The new high-performance Crucial P5 Plus PCIe Gen4 SSD rounds out Crucial’s stellar internal and external SSD product offerings such as the MX500, BX500, P5, P2, X8 and X6. Additionally, all P5 Plus SSDs come with our Crucial Storage Executive management software for performance optimization, data security and firmware updates, as well as free cloning software to ensure easy installation right out of the box.

As Micron’s global consumer brand, Crucial is uniquely able to connect millions of customers to the innovation and technology that Micron has been perfecting for more than four decades. For 25 years, online tools like the Crucial System Scanner have made it easy for customers such as content professionals, gamers, PC enthusiasts and DIY system builders to find compatible memory (DRAM) and storage (SSD) products for more than 175,000 desktops, laptops, and workstations. Crucial products are available on crucial.com and worldwide from leading retail and e-tail stores, commercial resellers and system integrators, enhancing system performance and user productivity on every continent.

Follow us online!
Facebook: www.facebook.com/crucialmemory
Twitter: www.twitter.com/crucialmemory
YouTube: www.youtube.com/crucialmemory

Micron CPG Media Relations Contact:

teamM Crucial
[email protected]

About Micron Technology, Inc.

We are an industry leader in innovative memory and storage solutions. Through our global brands — Micron^® and Crucial^® — our broad portfolio of high-performance memory and storage technologies, including DRAM, NAND, 3D XPoint™ memory and NOR, is transforming how the world uses information to enrich life for all. Backed by more than 40 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, 5G, machine learning and autonomous vehicles, in key market segments like mobile, data center, client, consumer, industrial, graphics, automotive and networking. Our common stock is traded on the Nasdaq under the MU symbol. To learn more about Micron Technology, Inc., visit micron.com.

© 2021 Micron Technology, Inc. All rights reserved. Information, products, and/or specifications are subject to change without notice. Neither Crucial nor Micron Technology, Inc., is responsible for omissions or errors in typography or photography. Micron, the Micron logo, Crucial and the Crucial logo are trademarks or registered trademarks of Micron Technology, Inc. All other trademarks are the property of their respective owners.

_______________________________

¹ Typical I/O performance numbers as measured using CrystalDiskMark® with a queue depth of 128 and write cache enabled. Fresh out-of-box (FOB) state is assumed. For performance measurement purposes, the SSD may be restored to FOB state using the secure erase command. System variations will affect measured results. When installed in a Gen3 system, typical read/write speeds are 3300/2700MB/s.

² Mean time to failure (MTTF) can be predicted based on component reliability data using the methods referenced in the Telcordia SR-332 reliability prediction procedures for electronic equipment and is validated in Reliability Demonstration Test (RDT).

³ Based on internal testing and comparison to Crucial’s prior-generation SSD, the Crucial P5 SSD with NVMe in similar capacities.

⁴ Based on internal testing and comparison to Crucial’s prior-generation SSD, the Crucial P5 SSD with NVMe in similar capacities.

⁵ Check your system compatibility at www.crucial.com by utilizing our online Crucial System Scanner or System Advisor compatibility tools.